TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 7:00ET Challenger Job Cuts; 8:30ET Weekly Jobless Claims, Trade Balance; 9:00ET Fed's Mester speaks; 10:40ET Fed's Kashkari speaks; 11:30ET Fed's Barkin speaks; 12:00ET Fed's Daly speaks; 12:15ET Fed's Barr speaks TODAY’S HIGHLIGHTS: Biden announces $9 billion more in student debt relief; total approved
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its target price lifted by Oppenheimer from $14.00 to $22.00 in a report issued on Monday, MarketBeat.com reports. They currently have an outperform rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued […]
Alpine Immune Sciences (NASDAQ: ALPN) has recently received a number of price target changes and ratings updates: 9/1/2023 – Alpine Immune Sciences had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $19.00 price target on the stock. 8/31/2023 – Alpine Immune Sciences had its “buy” rating reaffirmed by analysts at HC […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday after Wedbush raised their price target on the stock from $17.00 to $19.00. Wedbush currently has an outperform rating on the stock. Alpine Immune Sciences traded as high as $14.92 and last traded at $13.99, […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 477,690 shares changed hands during trading, an increase of 256% from the previous session’s volume of 134,176 shares.The stock last traded at $12.60 and had previously closed at $12.20. Alpine Immune Sciences Price Performance The company has […]